Your Account
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS
Preliminary Results of the Impact of Multiple Sclerosis Symptoms (IMSS) Survey Presented at RIMS Annual Conference
The 29th annual RIMS Conference held between 27 and 29 June 2024, marked a significant milestone for the MS community…
Impact of Multiple Sclerosis Symptoms (IMSS) – Where are we now and what can you do?
EMSP and 25 member organisations have launched their pan-European survey on the Impact of Multiple Sclerosis Symptoms (IMSS) in May…
EMSP joins new EU funded project called More-EUROPA
While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real-world data (RWD)…
MS Nurse PRO now available in Hungarian
MS Nurse PRO is pleased to announce that they are growing the nursing community. The platform is now also available…
Paediatric MS: Our Recommendations for Caregivers
Multiple Sclerosis was once considered a disease occurring exclusively in adulthood, however, there is growing recognition that MS can be…
MS Community Advisory Board (MS CAB) launched
In December 2021, EMSP launched a new initiative called the Multiple Sclerosis CommunityAdvisory Board (CAB), through which we intend to…
